Investors Chronicle covered Augmentum in their article “Technology Stocks for the New Normal”.
“A trading update for the six months to 30 September 2020 highlights just why the offer is worth taking up. Augmentum’s diversified portfolio of 18 private fintech companies offer innovative technologies, asset-light business models and have adapted well to the new ‘normal’. Many are performing incredibly well.”
“Offering one of the few opportunities for public markets investors to access the fintech sector, Augmentum has scarcity value as well as solid prospects of delivering decent NAV growth. The shares are well up on the 102.4p entry point in my 2019 Bargain Shares Portfolio, and the retail offer (closes at 5pm on 29 October) is worth taking up. Buy.”
Read the full article here